The team’s entry point was a subtle mutation in histone H3, one of the core protein spools around which DNA is wound. They changed lysine 37, an amino acid predicted to make direct contact with the DNA backbone, into an alanine, creating the H3K37A mutant. The idea was straightforward: if this residue helps grip DNA, removing it should loosen the wrap. That is precisely what happened, but the downstream effects were anything but subtle. Cells carrying H3K37A began degrading their histones, a hallmark of chromatin instability, and their TORC1 kinase went into overdrive. Hyperactive TORC1 is normally a sign of a cell awash in nutrients; here it appeared without any change in the food supply, driven instead by a single altered amino acid in the genome’s packaging material.

To understand whether this TORC1 hyperactivation was merely a side effect or something with real consequences, the researchers threw a pharmacological wrench into the pathway. When they inhibited TORC1 in H3K37A cells, the cells died. This was the study’s first surprise, because TORC1 inhibition is usually survivable, if uncomfortable, for yeast. The toxicity was not a general property of chromatin instability, either. The team compared H3K37A to cells carrying wild-type histone H3 in which chromatin stability had been undermined by other means. Those cells also lost histones and also showed hyperactivated TORC1, yet they tolerated TORC1 inhibition just fine. Something about the H3K37A mutation specifically, rather than loose chromatin per se, primed cells for catastrophe when the nutrient-sensing pathway was throttled back.

The genetic interactions sharpened that conclusion. When the researchers combined H3K37A with mutations that destabilize chromatin in an otherwise wild-type histone context, the defects did not simply add up; they compounded. Histone loss grew worse, TORC1 activity climbed higher, and lethality during TORC1 inhibition became more severe. This synergy suggests that H3K37A and general chromatin instability damage overlapping but distinct aspects of genome packaging, and that the cell can absorb a certain amount of damage from either source alone. Pushed from both directions at once, the buffering capacity collapses. The result is a dose-response relationship between chromatin integrity and TORC1 control that had not been appreciated before, positioning histone-DNA contacts as an upstream restraint on one of the cell’s most consequential signaling pathways.

Why would a wobbly nucleosome care about a nutrient kinase? The answer, according to transcriptome profiling, lies in the mitochondria. The gene expression analysis revealed that H3K37A cells misregulate mitochondrial retrograde signaling, a stress-response program through which dysfunctional mitochondria inform the nucleus and trigger compensatory metabolic rewiring. In yeast, this pathway is classically activated when respiratory function falters, allowing cells to reconfigure carbon metabolism and survive on fermentation. In the mutant, this program was already deregulated at baseline, and inhibiting TORC1 made the derangement dramatically worse. The combination of a strained retrograde response and a suppressed growth pathway proved lethal, indicating that the two systems normally cooperate to keep mitochondrial stress manageable during metabolic adaptation.

The mechanistic thread connecting chromatin to mitochondrial function turned out to be protein import. The researchers found that H3K37A cells were defective in importing at least one oxidative phosphorylation, or OXPHOS, subunit into the mitochondria. OXPHOS complexes are assembled from components made in the cytosol and threaded through mitochondrial membrane transport machinery; a bottleneck at this step starves the respiratory chain of parts and undermines energy production. Defective import of an OXPHOS subunit provides a concrete, testable link between the nuclear defect and the mitochondrial phenotype, explaining how a histone mutation expressed in the nucleus can compromise the electron transport chain embedded in the inner mitochondrial membrane.

Two rescue experiments cemented the causal chain. First, when the team inactivated the retrograde pathway itself, the toxicity of TORC1 inhibition in H3K37A cells was prevented. This may seem paradoxical, since the retrograde response is usually framed as protective, but a misfired or incomplete retrograde program can apparently be worse than none at all, pushing cells into a metabolic configuration incompatible with reduced TORC1 activity. Second, neutralizing reactive oxygen species, the chemically reactive byproducts of mitochondrial electron leakage that accumulate when respiration goes awry, also blocked the lethality. Together, these results sketch a coherent pathway: chromatin instability deregulates retrograde signaling, retrograde dysfunction impairs mitochondrial protein import and respiratory capacity, ROS accumulate, and the cell crosses a viability threshold when TORC1 is simultaneously inhibited.

The conceptual payoff is the demonstration of bidirectional communication between chromatin and TORC1. The canonical view has TORC1 sitting at the top of a signaling hierarchy, phosphorylating downstream effectors that include chromatin-modifying enzymes and transcriptional regulators, thereby imposing nutrient-dependent patterns of gene expression. The new data invert part of that picture. Chromatin stability, embodied in a single histone residue that touches DNA, acts as an input that constrains TORC1 output. Lose that constraint and TORC1 hyperactivates, independent of nutrient status. This reframes chromatin not merely as a passive target of metabolic signaling but as an active participant in metabolic homeostasis, with histone-DNA contacts serving as a structural sensor whose integrity feeds back into growth control.

The study also assigns a previously unknown job to histone H3 lysine 37. Beyond its structural role in the nucleosome, the residue appears to have an additional functionality that protects mitochondrial regulation during metabolic stress adaptation. That kind of dual assignment is becoming a theme in chromatin biology, where histone residues are increasingly recognized as nodes connecting genome architecture to cellular physiology. It also raises evolutionary questions about why a DNA-contacting residue would be conserved partly for its role in mitochondrial governance, and whether analogous histone mutations in other organisms, including human disease variants, produce comparable metabolic vulnerabilities.

For the broader research community, the work opens several practical avenues. Cells with compromised chromatin may be silently hyperactivating TORC1, confounding experiments that interpret TORC1 activity purely as a readout of nutrient availability. Conversely, therapies that inhibit TOR signaling, a strategy under active investigation in cancer and aging research, could carry unappreciated risks for cells with chromatin instability, a common feature of tumors. And the mitochondria-centered toxicity mechanism suggests that antioxidants or interventions targeting retrograde signaling might mitigate such risks in susceptible contexts. What began as a question about a single lysine in a histone tail region has ended as a demonstration that the genome’s packaging material helps guard the cell’s energy supply, and that when the packaging fails, the growth-control machinery and the mitochondria fail with it.

Subject of Research: How chromatin stability regulates TORC1 signaling and mitochondrial homeostasis in yeast

Article Title: Chromatin stability safeguards mitochondrial homeostasis and restrains TORC1 signaling

Article References: Sigamani, V., Yousuf, M., Johnson, D. L., Strahl, B. D., & Laribee, R. N. (2026). Chromatin stability safeguards mitochondrial homeostasis and restrains TORC1 signaling. PLOS Genetics, 22(10), e1012330. https://doi.org/10.1371/journal.pgen.1012330

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012330

Keywords: chromatin, TORC1, histone H3, mitochondria, retrograde signaling, yeast genetics, reactive oxygen species, OXPHOS, nutrient signaling, histone degradation, PLOS Genetics, metabolic stress

The foundation of the argument rests on the remarkable genetic and biochemical alterations that mitochondria undergo in tumors. Unlike most organelles, mitochondria carry their own genome, a small circular chromosome that encodes essential components of the oxidative phosphorylation machinery. The review catalogs somatic mitochondrial DNA mutations in a striking range of malignancies, from primary brain tumors to breast, gastric, bladder, lung, colorectal, and ovarian cancers. In high-grade prostate cancer, for example, studies cited by the authors show that oxidative phosphorylation remodeling involves mitochondrial DNA mutations and increased succinate oxidation. Single-cell analyses in colorectal cancer reveal heteroplasmy, the coexistence of mutant and wild-type mitochondrial genomes within individual cells, adding another layer of variability that tumors can draw upon. Mitochondrial DNA methylation changes have even been linked to bone metastasis in renal cell carcinoma, suggesting that the organelle’s genome participates in epigenetic regulation of aggressive behavior.

Copy number alterations add a second dimension to this genomic instability. Across human cancers, mitochondrial DNA copy number varies widely, and the direction of change carries different prognostic implications depending on context. Some studies report that high mitochondrial DNA copy number predicts poor outcomes in advanced colon cancer, while others find that decreased mitochondrial DNA content accompanies colorectal cancer progression. Mendelian randomization analyses have even probed whether inherited differences in mitochondrial DNA copy number influence cancer risk itself. The review also highlights circulating mitochondrial DNA in serum as a potential biomarker in lung cancer, and altered copy number as associated with venous thromboembolism in cancer patients, underscoring how mitochondrial perturbation echoes far beyond the tumor cell.

Beyond the genome, the review emphasizes the dynamic behavior of mitochondria, their constant cycling between fusion and fission, as a hallmark of malignancy. The fission mediator DRP1 emerges as a recurring villain. In ovarian cancer cells, DRP1- and MFN2-mediated dynamics contribute to cisplatin chemoresistance. In colon cancer, DRP1 activation promotes fatty acid-driven metabolic reprogramming that potentiates WNT signaling. Head and neck cancers exploit DRP1 to induce glycolysis through a FOXM1/MMP12 axis, while KRAS-mutant lung cancer cells use DRP1 to enhance lactate utilization. In hepatocellular carcinoma, DRP1-driven fission promotes proliferation through crosstalk between p53 and NF-κB pathways, and in glioblastoma, Rab32 regulates ERK/DRP1-mediated fission to drive migration and invasion. On the fusion side, OPA1 and MFN1 support liver tumor cell metabolism and growth, and OPA1 inhibition curtails breast cancer expansion. A notable study in Nature Cancer showed that limiting mitochondrial plasticity by targeting DRP1 reduces breast cancer brain metastases, hinting that the fission machinery itself is druggable.

The review then turns to mitochondrial enzymes as oncogenic actors, a theme crystallized by the tricarboxylic acid cycle proteins. Mutations in isocitrate dehydrogenase, IDH1 and IDH2, produce the oncometabolite 2-hydroxyglutarate and are now established drivers in glioma and acute myeloid leukemia with dedicated inhibitors in the clinic. Succinate dehydrogenase subunit mutations predispose carriers to familial pheochromocytoma and paraganglioma, and SDH deficiency underlies the Carney triad and related syndromes. Fumarate hydratase mutations cause hereditary leiomyomatosis and renal cell cancer, and loss of this enzyme triggers combined respiratory chain defects while the accumulated fumarate inhibits DNA demethylases, producing epigenetic dysregulation. These examples demonstrate a profound principle: when mitochondrial metabolism is broken, the metabolites themselves become signaling molecules that reshape the epigenome and activate programs of transformation.

Central to the review is the concept of mitochondrial retrograde signaling, the communication route by which a stressed organelle instructs the nucleus. The authors describe how dysfunctional mitochondria induce changes in gene expression through several converging pathways. Reactive oxygen species occupy a paradoxical position here. At moderate levels, mitochondrial ROS act as proliferative signals essential for KRAS-mediated tumorigenicity, but excessive oxidation damages macromolecules and can trigger cell death. The review details how ROS regulate proliferating cells, shape the breast tumor microenvironment, influence tumor-infiltrating immune cells and immunotherapy responses, and, through the LON-PYCR1 axis, maintain an immunosuppressive milieu that promotes metastasis. ROS also engage the Nrf2 antioxidant transcription program, which tumors frequently hijack, and modulate autophagy and mitophagy, the quality-control systems that cancer cells repurpose for survival under metabolic stress.

A second major arm of retrograde communication is the mitochondrial unfolded protein response, or mtUPR, a stress pathway mediated in mammals by the transcription factor ATF5. When protein folding inside mitochondria fails, ATF5 activates a transcriptional program that restores organelle function, but tumor cells co-opt this response to survive proteotoxic stress. The review notes that mtUPR activation is associated with HER2-overexpressing breast cancer and that ATF5 is overexpressed in epithelial ovarian carcinomas, where its interference increases apoptosis through BCL-2 downregulation. The integrated stress response, including the GCN2-ATF4 branch that allows tumor cells to withstand nutrient deprivation, further extends this survival network. Relatedly, pharmacological disruption of IRE1α has been shown to reprogram the tumor microenvironment and enhance anti-tumor immunity in prostate cancer and to cooperate with antiangiogenic therapy in triple-negative breast cancer, illustrating how stress signaling pathways intersect with treatment strategies.

Calcium handling constitutes a third retrograde channel, and the review gives it detailed treatment. Mitochondria buffer cytosolic calcium at mitochondria-associated ER membranes, and dysregulation of ryanodine receptor calcium channels has been shown to initiate mitochondrial retrograde signaling. In cancer cells, the LON protease upregulation triggers NCLX-mediated mitochondrial calcium release, contributing to cisplatin resistance, while calcium/calmodulin-dependent protein kinase II drives colon cancer proliferation and migration through ERK1/2 and p38 pathways. A FGF19/SOCE/NFATC2 circuit facilitates self-renewal of liver cancer stem cells, and mitochondrial dysfunction induces radioresistance in colorectal cancer by activating a calcium-dependent PDP1-PDH-histone acetylation signaling cascade. Single-organelle imaging studies showing oxidative bursts propagating from mitochondria toward the endoplasmic reticulum reveal how precisely these signals can be timed and localized. The review also describes mitochondrial-encoded peptides such as MOTS-c, which translocate to the nucleus to regulate gene expression during metabolic stress, and the cofactor GPS2, which physically shuttles from mitochondria to the nucleus in mammalian retrograde signaling.

Perhaps the most provocative section concerns intercellular mitochondrial trafficking. Tumor cells do not keep their damaged organelles to themselves. Recent work shows that cancer cells transfer damaged mitochondria to cancer-associated fibroblasts, promoting tyrosine kinase inhibitor tolerance in EGFR-mutant lung cancer, and that intercellular nanotubes mediate mitochondrial exchange between cancer and immune cells, subverting anti-tumor immunity. This horizontal movement of organelles within the tumor microenvironment adds a social dimension to mitochondrial dysfunction, suggesting that retrograde signaling operates not only within cells but across them, reshaping the ecology of the tumor as a whole.

The review closes by mapping therapeutic opportunities and honest gaps in knowledge. Emerging strategies include small-molecule modulators of the mitochondrial calcium uniporter, ROS-scavenging nanomedicines, mitochondrial-targeted antioxidants such as MitoQ derivatives that inhibit breast cancer and glioma proliferation, mitochondrial HSP90 inhibitors with activity in gliomas and prostate cancer models, and ClpP protease activators such as dordaviprone that show promise in KRAS-mutant pancreatic cancer. Combination regimens with immune checkpoint inhibitors are highlighted as a particularly promising frontier, given the immunomodulatory effects of mitochondrial stress. Yet the authors are candid about what remains unknown: the spatiotemporal dynamics of retrograde signals, the context-dependent dual roles of mitochondrial stress responses that can either suppress or promote tumors, and the integration of multi-omics data to identify predictive biomarkers all demand further work. Their conclusion is measured but forward-looking: mitochondrial retrograde signaling stands as a plausible target for new cancer interventions, and the task now is to translate mechanistic insight into clinically actionable approaches.

Subject of Research: Disrupted mitochondrial homeostasis and retrograde signaling in cancer progression

Article Title: Cancer-associated mitochondrial homeostasis disrupted and retrograde signaling activated

Article References: Liu, P., Wang, Z., Xi, S., & Wang, Y. (2026). Cancer-associated mitochondrial homeostasis disrupted and retrograde signaling activated. Medical Oncology, 43(11), Article 309. https://doi.org/10.1007/s12032-026-03405-4

Image Credits: AI Generated

DOI: 10.1007/s12032-026-03405-4

Keywords: mitochondria, retrograde signaling, cancer metabolism, mitochondrial DNA mutations, reactive oxygen species, mitochondrial unfolded protein response, calcium signaling, DRP1, tumor microenvironment, oncometabolites, immunotherapy, ATF5

The team focused on the mitochondrial calcium uniporter, or MCU, a channel protein embedded in the inner mitochondrial membrane that ferries calcium ions from the cytosol into the mitochondrial matrix. In mammals, the MCU complex includes pore-forming MCU proteins regulated by accessory components called MICU and EMRE, and decades of work have established that mitochondrial calcium homeostasis is essential for energy production, cell survival, and the decision between life and death. Plants possess their own family of MCU proteins: Arabidopsis carries six putative MCU orthologs, each with a conserved transmembrane domain, a pore loop, and a signature DVME sequence. Previous studies had shown that MCU1, MCU2, MCU3, and MCU5 localize to mitochondria, while MCU6 can target both mitochondria and chloroplasts, and that a triple mutant lacking MCU1, MCU2, and MCU3 shows reduced calcium uptake in roots. What remained unknown was what happens to the entire cell when this calcium gatekeeping system is disturbed.

To answer that question, the researchers first confirmed where the six MCU proteins reside and when they are active. Using fluorescent YFP tags in stable transgenic plants, they observed that the MCU proteins colocalize with mitochondrial markers in leaf and root cells. GUS staining revealed tissue-specific expression patterns: all six genes are active in the root stele, MCU3 is highly expressed in the root apex and cortex, MCU6 dominates the basal meristem, and MCU3, MCU4, and MCU6 are expressed in guard cells. This map of expression hinted that different MCU family members might play specialized roles in different tissues, but also that they share a common job as mitochondrial calcium channels.

The critical technical advance came from genetics. Because the six MCU genes are functionally redundant, the team crossed single mutants to build a sextuple knockdown line, mcu1-6, in which all six genes are expressed at reduced levels. They also created plants that massively overexpress MCU2, with one line showing a ninefold increase in transcript abundance. To watch calcium dynamics in real time, they targeted the calcium-sensitive luminescent reporter aequorin to the mitochondrial matrix and to the cytosol, then challenged seedlings with mannitol, which mimics drought-induced osmotic stress, and sodium chloride, which imposes salt stress. The results were unambiguous. Overexpressing MCU2 amplified the mitochondrial calcium surge, producing higher peak amplitudes and larger response curves, while the sextuple mutant blunted the response, reducing peak amplitudes by an average of 21 percent under mannitol and 26 percent under salt. Crucially, cytosolic calcium signals were unchanged in both lines, demonstrating that MCUs specifically tune mitochondrial calcium uptake without substantially buffering the cytosolic calcium wave that sweeps through stressed cells.

With the calcium phenotype established, the researchers turned to transcriptomics to see how the cell responds. They compared gene expression in the MCU2 overexpression line and the sextuple mutant against two reference conditions: untreated wild type and wild type treated with antimycin A, a drug that blocks the mitochondrial electron transport chain and classically induces the mitochondrial retrograde response. The comparison produced a surprise. Both MCU-perturbed genotypes activated a broad transcriptional program affecting mitochondrial proteostasis—genes encoding mitoribosomal proteins, oxidative phosphorylation complex subunits, the mitochondrial protein import machinery, and matrix proteases were all upregulated. Chaperone genes from four different compartments were induced as well: mitochondrial Hsp70 proteins, cytosolic chaperones, endoplasmic reticulum chaperones, and chloroplast chaperones. Western blots confirmed that mtHsp70 protein accumulated in the overexpression and knockdown lines. None of this multi-compartment chaperone induction appeared in antimycin-treated plants, and the alternative oxidase genes that normally mark the antimycin response stayed silent in the MCU mutants. In other words, disturbing mitochondrial calcium homeostasis triggers a stress program that is fundamentally different from the well-known retrograde response to respiratory chain damage.

The team interprets this pattern as the simultaneous activation of multiple compartment-specific unfolded protein responses. When proteins fail to fold properly in the mitochondrial matrix, the cell does not merely repair the mitochondrion; it appears to mobilize quality-control machinery in the cytosol, the ER, and the chloroplast as well. The researchers suggest that the underlying trigger is likely proteotoxic stress caused by disturbed mitochondrial translation. Supporting this idea, immunoblots showed that mitochondrially encoded subunits of respiratory complexes III, IV, and V—COB, COX1, ATP4, and ATP8—were reduced in the MCU-perturbed plants, while some nuclear-encoded subunits accumulated, creating a stoichiometric imbalance between the two genomes that supply the respiratory chain. This kind of mitonuclear protein imbalance is a classic activator of the mitochondrial unfolded protein response in animals, and the plant transcriptional profile resembled the interorganellar proteostasis program described in yeast, suggesting deep evolutionary conservation of this alarm system.

But the story did not end with transcription. Quantitative mass spectrometry of the proteome revealed that roughly half of the differentially abundant proteins in the sextuple mutant did not follow their transcript levels. Most strikingly, of the 194 cytosolic ribosomal protein genes whose abundance changed, about 58 percent showed reduced protein despite elevated mRNA. The same paradox appeared for chloroplast and mitochondrial ribosomal proteins and for pentatricopeptide repeat proteins, tetratricopeptide repeat proteins, and pseudouridine synthases—proteins that perform RNA editing and translation inside organelles. To investigate this apparent post-transcriptional repression, the researchers performed polysome profiling, separating actively translated mRNAs on polysomes from poorly translated ones on monosomes. While antimycin treatment caused a dramatic global shift from polysomes to monosomes, the MCU-perturbed plants showed only a mild global shift. Instead, translational efficiency analysis revealed a highly selective repression: genes involved in mitochondrial RNA metabolism and RNA modification lost translational efficiency in both the overexpression line and the sextuple mutant, with about 81 percent of RNA modification transcripts showing low translational efficiency. More than half of all transcriptionally induced cytosolic ribosomal protein mRNAs were also translationally repressed.

This selective translation program points to specific molecular effectors. In mammalian cells, the kinase GCN2 phosphorylates the translation initiation factor eIF2α to dampen protein synthesis during stress, while the TOR pathway senses energy status. The proteomic and immunoblot data told an unexpected tale: in the MCU-perturbed plants, eIF2α protein abundance and its phosphorylated form were both reduced, along with several translation initiation components, while TOR and the energy-sensing kinases KIN10 and KIN11 were largely unaffected. Antimycin treatment produced the opposite signature—increased KIN10 and KIN11 phosphorylation and reduced TOR, with no change in eIF2α. The authors propose that these two pathways mediate distinct types of mitochondrial stress: the TOR-S6K energy-sensing module handles the short-term, acute crisis caused by electron transport chain poisoning, whereas the eIF2α pathway manages the long-term, mild proteotoxic stress of chronic calcium imbalance. Counterintuitively, reducing eIF2α phosphorylation may be protective, preventing a catastrophic shutdown of protein synthesis during prolonged stress—an adaptive mechanism recently proposed in mammalian cells that now appears to operate in plants as well.

The physiological consequences of this molecular storm were visible to the naked eye. Plants with impaired MCU-controlled calcium homeostasis grew more slowly, with reduced leaf area that correlated with MCU2 expression levels in the overexpression lines. They also senesced prematurely, yellowing their older leaves weeks before wild type plants, and the timing of senescence tracked MCU2 dosage. Under osmotic stress induced by mannitol, both the overexpression lines and the sextuple mutant were significantly more sensitive than wild type, with markedly reduced fresh weight. These phenotypes establish a direct link between mitochondrial calcium homeostasis and the core stress biology traits of growth, aging, and stress resistance, and they suggest that the cross-compartmental proteostatic response is not merely a curiosity of gene expression but a determinant of plant fitness.

The study does have acknowledged limitations. The aequorin reporter lacks the sensitivity to resolve basal calcium levels or subtle changes after antimycin treatment, so modest differences in resting mitochondrial calcium cannot be excluded. The upstream regulators of MCU-mediated calcium signaling remain undefined, and future work with established calcium influx mutants such as osca and moca1 will be needed to position the uniporters within the broader calcium signaling hierarchy. The detailed molecular analysis also focused on a single high-expression MCU2 overexpression line, leaving open the possibility that individual MCU isoforms have distinct intrinsic activities. Even so, the findings provide a compelling new framework: mitochondrial calcium homeostasis, mitochondrial translation, and cellular proteostasis are woven together through an interconnected organelle quality control network that integrates transcriptional activation with selective translational repression. As climate change intensifies drought and salinity stress on crops, understanding and potentially engineering this calcium-triggered proteostatic alarm could offer new genetic targets for breeding more resilient plants.

Subject of Research: Mitochondrial calcium homeostasis and cross-compartmental proteostatic signaling in Arabidopsis

Article Title: Perturbation of mitochondrial Ca2+ homeostasis activates cross-compartmental proteostatic response in Arabidopsis

Article References: Perturbation of mitochondrial Ca2+ homeostasis activates cross-compartmental proteostatic response in Arabidopsis. (n.d.). https://doi.org/10.1007/s44154-026-00314-4

Image Credits: AI Generated

DOI: 10.1007/s44154-026-00314-4

Keywords: mitochondria, calcium signaling, mitochondrial calcium uniporter, Arabidopsis, unfolded protein response, proteostasis, retrograde signaling, eIF2α, translation regulation, plant stress, ribosomal proteins, senescence